SMTL ID : 8d4z.1 (1 other biounit)

Crystal structure of USP7 in complex with allosteric inhibitor FX1-3763

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

monomer

Ligands

1 x QBL: 1-({(7M)-7-[1-(azetidin-3-yl)-6-chloro-1,2,3,4-tetrahydroquinolin-8-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione(Non-covalent)

QBL.1: 24 residues within 4Å: Chain A: Y.19, F.86, M.87, Q.88, H.89, D.90, V.91, Q.92, Q.146, Q.200, L.201, M.202, R.203, F.204, M.205, K.215, H.251, D.254, N.255, H.256, G.257, Y.260, N.307, Y.309 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.19, A:D.90, A:F.204, A:F.204, A:H.251, A:Y.260, A:Y.309 Hydrogen bonds: A:M.87, A:V.91, A:Q.92, A:R.203, A:F.204 pi-Stacking: A:F.204, A:Y.309

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Futran, A.S. et al., Novel USP7 inhibitors demonstrate potent anti-cancer activity in models of AML, synergy with BCL2 inhibition, and a differentiated mechanism of action. To Be Published

Release Date

2023-09-20

Peptides

Ubiquitin carboxyl-terminal hydrolase 7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ubiquitin carboxyl-terminal hydrolase 7

Related Entries With Identical Sequence